AstraZeneca's ovarian cancer and anemia treatments meet goals in late-stage studies
British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Anemia | AstraZeneca | Cancer | Cancer & Oncology | Health | Ovarian Cancer | Ovaries | Study | UK Health